Skip to content

How Is Penile Implant Surgery Performed? Step-by-Step Guide

How Is Penile Implant Surgery Performed? Step-by-Step Guide

Penile implant surgery is an institutional care pathway connecting confirmation of the decision, individual preparation, product and team checks, implantation, safe discharge, device training, and follow-up; details vary by patient, device, and centre.

In brief: Penile implant surgery is not limited to the moment a device is placed. Confirmation of the clinical decision, infection and anaesthetic assessment, verification of the correct device and components, safe implantation, written discharge information, device-use training, and accessible follow-up are parts of one care pathway. Details vary with anatomy, previous surgery, the selected system, and institutional protocol.

1. The decision and surgical plan are reconfirmed

Before surgery, the clinical context of erectile dysfunction, treatments already considered, the individual's goals, and the limitations of an implant are reviewed again. The EAU guideline strongly recommends prosthesis implantation when other treatments fail or according to an informed patient preference, with full discussion of benefits and harms. [1] The candidacy-assessment article explains that decision framework.

2. Clinical preparation is individualised

General health, diabetes control, allergies, evidence of active infection, bleeding and thrombosis considerations, medicines, anaesthetic needs, and previous abdominal, pelvic, groin, or prostate surgery are assessed. Plans to stop or restart medicines require coordination among the prescribing clinician, surgical team, and anaesthetic team; the patient should not make these changes independently.

Official AMS 700 safety information lists active urogenital infection and active skin infection in the surgical region among its contraindications. That example is not a complete list for every implant: the institution must consult the current country- and version-specific instructions for the product actually used. [2]

3. Product, component, and team readiness are completed

Under institutional procedure, the surgical team verifies the selected system, model, size and component options, sterile-package integrity, expiry, and required instruments. Inflatable systems contain cylinders, a pump, and—depending on design—a reservoir; malleable systems use a pair of positionable implants. Product-specific preparation, placement, and testing must follow current manufacturer instructions and be performed within the trained physician's competence.

Boston Scientific's AMS 700 operating-room manual describes components and operating-room use for healthcare professionals. It illustrates why teams must work from the current official documentation for the actual device, rather than from a general web article. [3]

4. Operating-room safety checks are performed

Identity, procedure, site, and product verification; antibiotic and anaesthetic planning; sterility; team roles; and anticipated critical events belong within the institution's surgical-safety system. The World Health Organization Surgical Safety Checklist provides a shared structure for checks before anaesthesia, before incision, and before leaving the operating room. It does not replace local protocol or product-specific instructions. [4]

5. Implantation is tailored to the patient and system

The qualified surgeon prepares space within the corpora cavernosa and places implant components according to measurement and intra-operative findings. With an inflatable system, the pump is placed in the scrotal region; a three-piece system also requires a reservoir in an appropriate anatomical location. Previous pelvic surgery or anatomy can affect reservoir and approach planning. This summary is not a surgical technique: approach, sizing, and intra-operative decisions remain the trained implant surgeon's responsibility.

6. Discharge uses a safe transfer of information

Pain control, wound and dressing care, voiding, movement restrictions, medicines, the state in which the device is left, and scheduled review are assessed before discharge. Written information should explain which signs require contact, through which channel, and with what urgency. Fever, increasing redness or swelling, discharge, persistent bleeding, worsening pain, inability to pass urine, or unexpected device behaviour may require prompt clinical assessment.

There is no single universal duration for hospital stay, return to work, heavy activity, or sexual activity. Personal clearance depends on healing, pain, the procedure, workload, and review findings and must come from the surgical team. General internet timelines do not replace the institution's written plan.

7. Device training and continuity of follow-up are secured

Follow-up assesses wound healing, device position, and function. The timing of first activation and training for an inflatable device may vary by centre and patient. Training should cover locating the pump, correct operation, expected sensations, care information, and situations requiring help. Product identity and the implant card should remain accessible for future care and imaging decisions.

Institutional traceability checklist

  • Current, country-appropriate instructions for use and document revision
  • Clinical record of the patient- and product-selection rationale
  • Matching product, model, serial or lot details in the implant record
  • Operating-room safety and sterility records
  • Written discharge, urgent-contact, and follow-up plan
  • Record of patient training and implant-card delivery

Luvi Health's surgical-process support, training and operation, and technical-documentation layers are positioned to support this institutional information flow; they do not create a clinical protocol or transfer physician authority.

Professional boundary

This resource is not a surgical technique, personal preparation schedule, medicine instruction, or discharge clearance. The surgical plan, product choice, implantation, and follow-up are determined only by a trained specialist team using current guidelines, product documentation, and institutional procedures.

References

  1. EAU Guidelines on Sexual and Reproductive Health, Management of Erectile Dysfunction, 2026.
  2. Boston Scientific, AMS 700 Prescriptive Information.
  3. Boston Scientific, AMS 700 with MS Pump Operating Room Manual. Current country-specific instructions for the product used remain controlling.
  4. World Health Organization, Safe Surgery tools and WHO Surgical Safety Checklist.

Send message